Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Honey and Nigella Sativa in the Prophylaxis of COVID-19: A Randomized Controlled Trial

NCT04767087 is registered in ClinicalTrials.gov with Sohaib Ashraf as lead sponsor.

NCT NCT04767087
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04767087 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Honey and Nigella Sativa in the Prophylaxis of COVID-19: A Randomized Controlled Trial
Lead sponsor
Sohaib Ashraf
Phase
Phase 2/3
Overall status
Unknown status
Start date
March 5, 2021
Completion date
April 15, 2022
Enrollment
1,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19